Study at a glance
What was the question?
Does vitamin D status or supplementation during pregnancy relate to better maternal or infant health? The review separates changes in blood measurements from effects on specific health outcomes.
Who was studied?
Five core investigations examined women before or during pregnancy, and their babies. They used different starting concentrations, supplement comparisons and measurement times. The review also considers an infant-growth report that was later corrected.
What did the studies find?
Supplements raised blood status in several trials. Two trials did not show a clear overall benefit in the amount of mineral measured in babies’ bones. One found a possible benefit among winter births in an additional analysis. The other had a small imaging sample. A trial assigning supplements by chance did not show clear prevention of preeclampsia, a pregnancy complication. Associations based on observed blood status did not prove a treatment effect. The growth trial did not detect an infant-growth benefit.
What are the limits?
Not finding a clear difference does not prove treatments have identical effects. Missing measurements and selected groups limit how widely the findings apply. A recent diabetes report was excluded because of conflicting results within its report. These findings do not establish a personal dose, ideal blood target or conclusion about every pregnancy outcome.
Read the full article below ↓Giving vitamin D during pregnancy can raise a blood measurement without proving an improvement in maternal or infant health. The evidence also differs by outcome: a bone scan, preeclampsia and infant growth are separate questions. This Summary explains the main findings and uncertainties. The detailed assessment is in Vitamin D in Pregnancy: Maternal and Fetal Outcomes: Full Evidence Review.
What was studied?
The review examines five core investigations, plus an infant-growth finding reported in a paper that was later corrected. It also explains why a recent gestational-diabetes report was excluded after assessment. The studies used different populations, starting concentrations, treatment comparisons and times during pregnancy.
The usual status marker is 25-hydroxyvitamin D. It is different from vitamin D3 in a supplement and from the active hormone. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D explains these substances. Vitamin D Status vs Vitamin D Effect explains why changing a status measurement does not automatically establish a health benefit.
Did supplementation improve newborn bone measurements?
The UK MAVIDOS trial did not demonstrate an overall improvement in its main newborn bone-mineral-content measurement. A secondary analysis suggested a benefit among winter births. That finding deserves attention, but it came from one of several subgroup comparisons and does not replace the overall result. Women with markedly low screening concentrations were excluded, so the trial cannot settle every deficient-pregnancy question.
The Lebanese preg-D trial compared two active supplement regimens. Higher exposure improved maternal and cord blood measurements. It did not demonstrate a clear newborn bone-mineral-content benefit in the small group with usable scans. Many randomized participants lacked complete measurements. The result therefore does not prove that the regimens were equivalent.
Neither trial established fewer fractures. Bone Mineralisation, Turnover and Fractures Measure Different Outcomes explains why bone mineral measurements, bone turnover and fractures are different outcomes.
Did supplementation prevent preeclampsia?
Preeclampsia is a pregnancy complication. In the assessed VDAART comparison, there were 33 cases in the higher-exposure group and 34 in the comparison group, with 408 pregnancies in each. The randomized result did not demonstrate prevention, but its uncertainty also means it did not prove that every possible effect was absent.
Women who achieved higher vitamin D status had lower preeclampsia odds in a separate analysis. However, they were grouped by a later blood result, not simply by their randomized assignment. Other differences between them could affect the association. It cannot establish a personal preventive target.
The EAGeR analysis examined status before conception and early in pregnancy. Vitamin D was not randomized; the original trial concerned aspirin. An association with later preeclampsia became weaker after adjustment for body mass index, a measure relating weight to height. This does not prove that body size fully explains the association or that vitamin D treatment would change the risk. A blood concentration identified during an additional statistical analysis does not establish a treatment target.
What about blood status and infant growth?
The Hollis trial showed that vitamin D3 exposure changed the usual status marker. It did not demonstrate significant differences in how far the pregnancy had progressed at birth, birthweight or the need for more specialized care for newborn babies. Its main purpose was biochemical, and incomplete follow-up limits broader conclusions. Research exposure and monitored safety findings are not a personal supplementation plan.
The Bangladesh MDIG trial did not detect an infant-growth benefit in its principal growth report. A later correction changed numerical material while leaving the stated conclusion unchanged. This review uses only that finding without repeating unverified older numerical estimates. Infant growth is different from the newborn bone measurements in the other trials.
Why was the diabetes report excluded?
A recent report in women who already had gestational diabetes contained important conflicts in its numerical and statistical reporting. After examining the full report and supplement, the review excluded it from reliable benefit estimates. That does not mean vitamin D has been proved helpful or ineffective for diabetes. It means this report cannot reliably settle the question.
What does this mean?
The studies demonstrate biochemical responses more clearly than they establish broad clinical benefits. Some findings remain promising, some comparisons did not detect benefit, and some estimates are too uncertain for a firm conclusion. The evidence does not justify one universal claim about every pregnancy outcome or every population. It also does not establish a personal dose or ideal blood target.
Sources and access
This Summary uses the Full Evidence Review’s assessed studies and exclusions. The detailed review provides publication links, missing-material limits, correction information and the distinction between randomized and observational results. No additional studies are introduced.
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. Cooper C et al. Lancet Diabetes & Endocrinology. 2016;4:393 to 402.
Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial. Chakhtoura M et al. Journal of Clinical Endocrinology & Metabolism. 2026. Supplement DOI 10.6084/m9.figshare.32314851.v1.
Early pregnancy vitamin D status and risk of preeclampsia. Mirzakhani H et al. Journal of Clinical Investigation. 2016;126:4702 to 4715.
Preconception vitamin D status and subsequent risk of preeclampsia: A secondary cohort analysis from the EAGeR trial. Alkhalaf ZM et al. Pregnancy Hypertension. 2026;43:101417.
Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Roth DE et al. New England Journal of Medicine. 2018;379:535 to 546. 2021 correction: Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Same trial, not a separate study.
The role of vitamin D in pregnancy outcomes in gestational diabetes: a randomized controlled trial. Liu Y et al. Endocrine Connections. 2026;15:e250932. Assessed but excluded from reliable effect estimates for the reasons described above.
Related reading
Association of prenatal vitamin D concentration with the eruption time of the first primary tooth: A prospective cohort study
The study investigated the association between vitamin D levels during the first and second trimesters of pregnancy and the eruption time of the first primary tooth.
Original paper ↗Read more →Associations of Maternal Vitamin D Deficiency with Pregnancy and Neonatal Complications in Developing Countries: A Systematic Review
Pregnant women in Asia, the Middle East, Africa and Latin America are at risk of vitamin D deficiency (VDD) and prevalence throughout these regions are among the highest, globally.
Original paper ↗Read more →Correlation of Maternal Vitamin D Status in Early Pregnancy and Vitamin D Supplementation during Pregnancy with Atopic Dermatitis in Infants: A Prospective Birth Cohort Study
Objective: This study aimed to investigate the association of maternal first-trimester vitamin D levels and vitamin D supplementation during pregnancy with infant atopic dermatitis (AD) and to determine the effect of variables such as mode of conception on the association.
Original paper ↗Read more →Early pregnancy vitamin D and the risk of adverse maternal and infant outcomes: a retrospective cohort study
Previous evidence has suggested that lower gestational vitamin D levels might increase the risks of adverse pregnancy and birth outcomes.
Original paper ↗Read more →Effect of Vitamin D Supplementation on the Fetal Growth Rate in Pregnancy Complicated by Fetal Growth Restriction
The aim of the study was to check if the rate of fetal growth in pregnant women with FGR differs depending on whether the patient was supplemented with vitamin D in the recommended dose of 2000 IU, not supplemented at all, or supplemented with vitamin D in low doses.
Original paper ↗Read more →Effects of vitamin D in pregnancy on maternal and offspring health-related outcomes: An umbrella review of systematic review and meta-analyses
Vitamin D deficiency has been linked with several adverse maternal and fetal outcomes.
Original paper ↗Read more →Hypertensive disorders of pregnancy in low: and middle-income countries: a review of antenatal interventions to improve maternal outcomes
The majority of studies on interventions for hypertensive disorders of pregnancy in LMICs were randomized trials focused on efficacy.
Original paper ↗Read more →Longitudinal changes in vitamin D during twin pregnancy: association with maternal-neonatal outcomes
This study aimed to explore the relationship between maternal VD levels and maternal and neonatal outcomes in twin pregnancies.
Original paper ↗Read more →Maternal Circulating Vitamin D Level, Targeted Supplementation, and Perinatal Outcomes in Twin Pregnancy
The aim of this study was to assess whether vitamin D levels affect the outcomes of twin pregnancy and if targeted supplementation can improve perinatal outcomes.
Original paper ↗Read more →Maternal circulating Vitamin D3 levels during pregnancy and behaviour across childhood
Vitamin D deficiency during critical periods of development could lead to persistent brain alterations.
Original paper ↗Read more →Maternal Intake of Vitamin D Supplements during Pregnancy and Pubertal Timing in Children: A Population-Based Follow-Up Study
In this population-based follow-up study of 12,991 Danish boys and girls born 2000 to 2003, we investigated if maternal intake of vitamin D supplements during pregnancy was associated with pubertal timing in boys and girls.
Original paper ↗Read more →Maternal serum vitamin D level in early pregnancy and risk for preeclampsia: A case-control study in Southern Sweden
The aim of the present case-control study in Sweden was to assess the hypothesized association between low serum vitamin D concentrations in early pregnancy and the risk of developing preeclampsia since vitamin D may play a role in early placental development.
Original paper ↗Read more →Maternal vitamin D during pregnancy and offspring autism and autism-associated traits: a prospective cohort study
There has been a growing interest in the association between maternal levels of vitamin D during pregnancy and offspring autism.
Original paper ↗Read more →Maternal vitamin D levels during pregnancy and offspring schizophrenia
Conditional logistic regression models examined the association between maternal 25(OH)D levels and offspring schizophrenia.
Original paper ↗Read more →Maternal Vitamin D Status, Gestational Hypertension, and Preeclampsia: A Cross-Sectional Study in Urban Greece
We evaluated maternal and cord 25-hydroxyvitamin D [25(OH)D] at birth in an urban Greek cohort and examined associations with gestational hypertension and preeclampsia.
Original paper ↗Read more →Maternal vitamin D status in early pregnancy and its association with gestational diabetes mellitus in Shanghai: a retrospective cohort study
We aimed to assess maternal vitamin D status in early pregnancy and its relationships with the risk of GDM in a Chinese population in Shanghai.
Original paper ↗Read more →Maternal vitamin D status in pregnancy and molar incisor hypomineralisation and hypomineralised second primary molars in the offspring at 7 to 9 years of age: a longitudinal study
The study aimed to investigate associations between maternal vitamin D status during pregnancy and molar incisor hypomineralisation (MIH) and hypomineralised second primary molars (HSPM) among children.
Original paper ↗Read more →Newborn metabolomic perturbations associated with prenatal tobacco smoke exposure and early birth
In this study, we aimed to characterize the newborn metabolomic associations with early pregnancy maternal tobacco exposure biomarkers and early birth in 269 mother-child pairs in the Atlanta African American Maternal-Child Cohort (2016 to 2020).
Original paper ↗Read more →The Current Recommended Vitamin D Intake Guideline for Diet and Supplements During Pregnancy Is Not Adequate to Achieve Vitamin D Sufficiency for Most Pregnant Women
Data and banked blood samples collected in second trimester from a subset of 537 women in the APrON (Alberta Pregnant Outcomes and Nutrition) study cohort were examined.
Original paper ↗Read more →The High Prevalence of Vitamin D Deficiency and Its Related Maternal Factors in Pregnant Women in Beijing
The purpose of this study was to assess the vitamin D status of pregnant women residing in Beijing in winter and evaluate the impact of maternal factors on serum 25-hydroxyvitamin D [25(OH)D] levels.
Original paper ↗Read more →The relationship between maternal vitamin D status during third trimester of pregnancy and maternal and neonatal outcomes: A longitudinal study
The aim of the current study was to evaluate the relationship between maternal vitamin D status and gestational weight gain, maternal biochemical parameters, mode of delivery, and infants’ growth indices at birth.
Original paper ↗Read more →Original sources
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial
Published in Cooper C et al. Lancet Diabetes & Endocrinology (2016).
Publication details
Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. Cooper C et al. Lancet Diabetes & Endocrinology. 2016;4:393 to 402.
Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial
Published in Chakhtoura M et al. Journal of Clinical Endocrinology & Metabolism (2026).
Publication details
Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial. Chakhtoura M et al. Journal of Clinical Endocrinology & Metabolism. 2026. Supplement DOI 10.6084/m9.figshare.32314851.v1.
Early pregnancy vitamin D status and risk of preeclampsia
Published in Mirzakhani H et al. Journal of Clinical Investigation (2016).
Publication details
Early pregnancy vitamin D status and risk of preeclampsia. Mirzakhani H et al. Journal of Clinical Investigation. 2016;126:4702 to 4715.
Preconception vitamin D status and subsequent risk of preeclampsia: A secondary cohort analysis from the EAGeR trial
A secondary analysis of the EAGeR Trial (2006 to 2012), which was a multisite, prospective, double-blind, block-randomized, placebo-controlled clinical trial of women with regular menstrual cycles and 1 to 2 prior pregnancy losses.
Publication details
Preconception vitamin D status and subsequent risk of preeclampsia: A secondary cohort analysis from the EAGeR trial. Alkhalaf ZM et al. Pregnancy Hypertension. 2026;43:101417.
Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness
Published in Hollis BW et al. Journal of Bone and Mineral Research (2011).
Publication details
Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.
Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness
Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness.
Publication details
Vitamin D Supplementation during Pregnancy: Double Blind, Randomized Clinical Trial of Safety and Effectiveness. Hollis BW et al. Journal of Bone and Mineral Research. 2011;26:2341 to 2357. Correction: Erratum: Vitamin D supplementation during pregnancy: Double-blind, randomized clinical trial of safety and effectiveness. 2011.
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth
Published in Roth DE et al. New England Journal of Medicine (2018).
Publication details
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Roth DE et al. New England Journal of Medicine. 2018;379:535 to 546. 2021 correction: Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Same trial, not a separate study.
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth
Published in Roth DE et al. New England Journal of Medicine (2018).
Publication details
Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Roth DE et al. New England Journal of Medicine. 2018;379:535 to 546. 2021 correction: Vitamin D Supplementation in Pregnancy and Lactation and Infant Growth. Same trial, not a separate study.
The role of vitamin D in pregnancy outcomes in gestational diabetes: a randomized controlled trial
Published in Liu Y et al. Endocrine Connections (2026).
Publication details
The role of vitamin D in pregnancy outcomes in gestational diabetes: a randomized controlled trial. Liu Y et al. Endocrine Connections. 2026;15:e250932. Assessed but excluded from reliable effect estimates for the reasons described above.